B2RLaw advised Life Science Innovation Fund on its investment in a healthtech startup
B2RLaw has advised the Life Science Innovation Fund on its investment in AIDLAB, a telemedical startup. The aim of the investment is to develop a new product, AIDMED, a device which remotely diagnoses diseases, particularly sleep breathing and cardiac disorders.
The healthtech industry is experiencing noticeable growth during the current pandemic. Innovative solutions that allow certain activities to be performed remotely are relieving the burden on medical personnel while providing more comfortable conditions for patients. AIDMED’s solutions can reduce hospitalization periods to a minimum using artificial intelligence to analyze measurements.
The investor is a Polish VC, Life Science Innovation Fund, which invests in MedTech, Biotech and Health Care, and has invested in a number of successful companies such as BrainScan, Bioseco, LumiSep and LifeFlow.
B2RLaw’s consisted of Partner Szymon Syp, Ph.D. and Senior Associate Iga Wojtczak-Opala.
View more resources
Catch up on the very latest B2RLAW
announcements and news here.
B2RLaw has advised The Village Network, a Polish company creating Wioski.co, which is run by three female entrepreneurs, and supports […]
B2RLaw has appointed Andrzej Zając as Counsel to its Real Estate Practice. Andrzej is a next generation leader with a […]
B2RLaw has advised growth equity investors Kennet Partners and Digital+ Partners on their USD 30 million equity investment in Polish […]
B2RLaw is celebrating after being awarded Venture Capital Legal Advisor of the Year at the Polish Private Equity and Venture […]
B2RLaw has announced Edyta Zalewska as Partner in its 2021 promotion round, effective as of 1st May 2021. B2RLaw is also […]
B2RLaw is pleased to advise that it has been selected as a finalist of the PSIK Awards 2021 for Venture […]
Get in touch
Not sure who to contact? Let us help you find the right lawyer.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.